Loading…

Trial in Progress: A Randomized Phase II Study of MB-CART2019.1 Compared to Standard of Care Therapy in Patients with Relapsed/Refractory DLBCL Ineligible for High-Dose Chemotherapy and Autologous Stem Cell Transplantation - DALY 2-EU Trial

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.12784-12785
Main Authors:	Borchmann, Peter, Vandenberghe, Peter, Urbano-Ispizua, Alvaro, Haioun, Corinne, Lemonnier, Francois, Griskevicius, Laimonas, Maury, Sébastien, Holtkamp, Silke, Friedrichs, Birte, Zadoyan, Gregor, Hanssens, Linda, Overstijns, Toon, Assenmacher, Mario, Bethke, Ulf, Bürger, Iris, Reer, Olaf, Jaeger, Ulrich, Kersten, Marie José
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!